MC1834A1 - Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation - Google Patents

Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation

Info

Publication number
MC1834A1
MC1834A1 MC871896A MC1896A MC1834A1 MC 1834 A1 MC1834 A1 MC 1834A1 MC 871896 A MC871896 A MC 871896A MC 1896 A MC1896 A MC 1896A MC 1834 A1 MC1834 A1 MC 1834A1
Authority
MC
Monaco
Prior art keywords
hirudine
gene
preparing
functional block
plasmid encoding
Prior art date
Application number
MC871896A
Other languages
English (en)
French (fr)
Inventor
Loison G
Lemoine Y
Balland A
Labat N
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR868610090A external-priority patent/FR2601383B2/fr
Priority claimed from FR868616722A external-priority patent/FR2607516B2/fr
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of MC1834A1 publication Critical patent/MC1834A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC871896A 1986-07-10 1987-07-02 Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation MC1834A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR868610090A FR2601383B2 (fr) 1985-05-02 1986-07-10 Vecteurs perfectionnes d'expression de l'hirudine dans les levures, procede et produit obtenu
FR868616722A FR2607516B2 (fr) 1986-12-01 1986-12-01 Vecteurs perfectionnes d'expression d'un variant de l'hirudine dans les levures, procede et produit obtenu

Publications (1)

Publication Number Publication Date
MC1834A1 true MC1834A1 (fr) 1988-06-03

Family

ID=26225387

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871896A MC1834A1 (fr) 1986-07-10 1987-07-02 Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation

Country Status (20)

Country Link
US (2) US5591640A (ko)
EP (1) EP0252854B1 (ko)
JP (1) JP2733602B2 (ko)
KR (1) KR960013464B1 (ko)
AT (1) ATE153066T1 (ko)
AU (1) AU614933B2 (ko)
BG (1) BG80504A (ko)
CA (1) CA1341490C (ko)
CZ (1) CZ278268B6 (ko)
DE (1) DE3752063T2 (ko)
DK (1) DK175195B1 (ko)
ES (1) ES2103700T3 (ko)
FI (1) FI96966C (ko)
GR (1) GR3024368T3 (ko)
HU (1) HU214236B (ko)
MC (1) MC1834A1 (ko)
NO (1) NO179489C (ko)
PL (1) PL154118B1 (ko)
PT (1) PT85296B (ko)
RU (1) RU1776276C (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9015825D0 (en) * 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
SG49859A1 (en) * 1992-09-04 2002-03-19 Ucp Gen Pharma Ag Process for the production of protease inhibitors
TW282490B (ko) * 1992-12-15 1996-08-01 Ciba Geigy Ag
US5712114A (en) * 1995-06-06 1998-01-27 Basf Aktiengesellschaft Compositions for expression of proteins in host cells using a preprocollagen signal sequence
KR20010034305A (ko) 1998-01-23 2001-04-25 한센 핀 베네드 효모에서 원하는 폴리펩티드를 만드는 방법
KR100949722B1 (ko) 2002-08-12 2010-03-25 에이펙셀 (주) 마이크로 초미립 분쇄기
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
NO840200L (no) * 1983-01-28 1984-07-30 Cefus Corp Glukoamylase cdna.
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation

Also Published As

Publication number Publication date
KR880007727A (ko) 1988-08-29
US5591640A (en) 1997-01-07
EP0252854B1 (fr) 1997-05-14
CZ278268B6 (en) 1993-11-17
RU1776276C (ru) 1992-11-15
DK355887A (da) 1988-01-11
JP2733602B2 (ja) 1998-03-30
NO872878L (no) 1988-01-11
PL266756A1 (en) 1988-06-23
PL154118B1 (en) 1991-07-31
PT85296A (pt) 1988-07-29
NO179489B (no) 1996-07-08
NO179489C (no) 1996-10-16
US5902735A (en) 1999-05-11
KR960013464B1 (ko) 1996-10-05
PT85296B (pt) 1995-05-31
ATE153066T1 (de) 1997-05-15
AU7536687A (en) 1988-01-14
BG80504A (bg) 1993-12-24
DE3752063D1 (de) 1997-06-19
EP0252854A1 (fr) 1988-01-13
GR3024368T3 (en) 1997-11-28
CA1341490C (fr) 2005-08-30
FI873068A0 (fi) 1987-07-10
FI873068A (fi) 1988-01-11
HUT44616A (en) 1988-03-28
JPS6485082A (en) 1989-03-30
AU614933B2 (en) 1991-09-19
DK355887D0 (da) 1987-07-09
FI96966C (fi) 1996-09-25
CZ527787A3 (en) 1993-08-11
ES2103700T3 (es) 1997-10-01
DE3752063T2 (de) 1997-12-04
HU214236B (hu) 1998-03-02
DK175195B1 (da) 2004-07-05
FI96966B (fi) 1996-06-14
NO872878D0 (no) 1987-07-10

Similar Documents

Publication Publication Date Title
MC1834A1 (fr) Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
EP0329822A3 (en) Nucleic acid amplification process
DE69523915D1 (en) Synthetische leaderpeptid-sequenz
ATE332382T1 (de) Pflanzen, die eine modifizierte stärke synthetisieren, verfahren zu ihrer herstellung sowie modifizierte stärke
BR0005091A (pt) Sequências de nucleotìdio codificando para o gene poxb
EP0316018A3 (en) Modification of dna sequences
EP0641215A4 (en) PROTEASE-RESISTANT ANALOGS OF THROMBOMODULIN.
DE3853145D1 (de) Verfahren zur Herstellung von xbaI-Restriktionsendonuklease und -methylase.
ES2052497T3 (es) Un metodo para exportar productos de gen al medio de crecimiento de bacterias gram-negativas.
GB9806113D0 (en) Control
DE3853143D1 (de) Verfahren zur Herstellung von AccI-Restriktionsendonuklease und -methylase.
DE3854373D1 (de) Verfahren zur Herstellung der Afl II Restriktionsendonuklease.
DE3586410D1 (de) Verfahren zur herstellung von neutraler protease.
IT8620122A0 (it) Nuovo procedimento di purificazione della diamide dell'acido ossalico.
GB8823728D0 (en) Recombinant plasmid dna ppr-il2-19, coding for synthesis of human interleukin-2, method of bacteria escherichia coli vniigenetika vl 903 (ppr-il2-19) as producer of human interleukin-2, containing it
IT8622638A0 (it) Procedimento di purificazione della diamide dell'acido ossalico.
MC1586A1 (fr) Preparation de sequences d'adn codant pour des precurseurs de pro-insuline modifies
GB8823729D0 (en) Recombinant plasmid dna ppr-il2-19, coding for synthesis of human interleukin-2, method of bacteria escherichia coli vniigenetika vl 903 (ppr-il2-19) as producer of human interleukin-2, containing it
KR19980066405A (ko) 대장균에서 인간 적혈구 형성 자극인자의 대량 생산방법
UA19039A (uk) Спосіб одержаhhя еритропоетиhу людиhи
KR19980066404A (ko) 대장균에서 인간 적혈구 형성 자극인자의 대량 생산방법
ZA859841B (en) Process for purifying tumor necrosis factors and for producing recombinant dna molecules coding for tumor necrosis factor-like compounds and tumor necrosis factors
FR2682376B1 (fr) Reactif utile pour le clivage et procede d'utilisation de ce reactif d'un groupe protecteur.
BG52178B2 (en) Method for chemical synthesis and expression of the gene of human noncystein -interferon

Legal Events

Date Code Title Description
YP Annual fee paid